YLYannis Lassoued

Yannis Lassoued

*This is an algorithmically generated author record based on publicly available information.

Yannis Lassoued has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Andreas Werner

    Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil

    1 shared publication
  • André Birgy

    Inserm, IAME UMR 1137, Université Paris Cité and Université Sorbonne Paris Nord , Paris

    1 shared publication
  • Bruno Franji

    Centre Hospitalier Intercommunal de Créteil, Clinical Research Centre, Université Paris Est, IMRB-GRC GEMINI , Créteil

    1 shared publication
  • Christophe Batard

    Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil

    1 shared publication
  • Corinne Levy

    ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France

    1 shared publication
  • Fabienne Cahn Sellem

    Association Clinique et Thérapeutique Infantile du Val-de-Marne France (ACTIV) , Créteil

    1 shared publication

Latest Publications

  • Impact of RSV Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis

    by Inès Fafi, Corinne Levy, André Birgy, Stéphane Bechet, Andreas Werner, Christophe Batard, Bruno Franji, Yannis Lassoued, Fabienne Cahn Sellem, Romain Basmaci, et al.

    Background: Acute otitis media (AOM) is the leading cause of antibiotic prescription in children. Respiratory syncytial virus (RSV) is suspected to play an important role in AOM. The aim of this study was to estimate the impact of RSV immunization on the rate of subsequent AOM in children, as this effect remains unknown. Methods: We conducted an interrupted time-series analysis based on a French network involving 110 ambulatory pediatricians, trained in pediatric infectious diseases (PARI network). All ambulatory visits for AOM, from June 2017 to February 2025 were included. The main outcome was the monthly rate of pediatric ambulatory visits for AOM in infants aged < 12 months per 1000 pediatric ambulatory visits over time, assessed by a seasonally adjusted quasi-Poisson regression model. Bronchiolitis and urinary tract infections (UTI) were analyzed over the same period, as positive and negative controls, respectively. Results: We included 70 452 cases of AOM, 13 284 bronchiolitis and 814 UTI. The rate of AOM per 1000 visits in infants aged < 12 months significantly decreased after RSV immunization implementation (−23.7%, 95% CI −37.6 to −9.7, P = .0014), whereas no significant change was observed in older age groups. We observed similar trends for bronchiolitis. The monthly rate of UTI did not significantly decrease. Conclusions: RSV immunization led to a strong reduction of AOM rate in infants aged < 12 months. Beyond its efficacy in preventing RSV-related lower respiratory infections in infants aged < 12 months, RSV immunization may contribute to reduce the burden of AOM in children.